Macrophage inflammatory protein-1α (MIP-1α) and leukemia inhibitory factor (LIF) protect the repopulating ability of purified murine hematopoietic stem cells in serum-deprived cultures stimulated with SCF and IL-3;La presenza in coltura di macrophage inflammatory protein-1α (MIP-1α) o di leukemia inhibitory factor (LIF) protegge la capacità delle cellule staminali marine purificate di colonizzare il midollo dopo trapianto

Annali dell'Istituto Superiore di Sanita

Volumn 35, Issue 4, 1999, Pages 553-562

  Tanosaki, Ryuji ^a   Ashihara, Eishi ^a   Alessandrini, Laura ^b   Migliaccio, Giovanni ^b   Migliaccio, Anna Rita ^b  

^a NEW YORK BLOOD CENTER   (United States)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Bone marrow transplantation; Ex vivo expansion; Hematopoietic stem cells; Leukemia inhibitory factor; Macrophage inflammatory protein 1

Indexed keywords

GROWTH INHIBITOR; INTERLEUKIN 3; INTERLEUKIN 6; LEUKEMIA INHIBITORY FACTOR; LIF PROTEIN, MOUSE; LYMPHOKINE; MACROPHAGE INFLAMMATORY PROTEIN 1; RECOMBINANT PROTEIN; STEM CELL FACTOR;

ANALYSIS OF VARIANCE; ANIMAL; ARTICLE; C57BL MOUSE; CELL DIVISION; CELL SEPARATION; CULTURE MEDIUM; CYTOLOGY; DRUG EFFECT; FEMALE; GENOTYPE; HEMATOPOIETIC STEM CELL; METHODOLOGY; MOUSE; POLYMERASE CHAIN REACTION; STIMULATION; TIME;

ANALYSIS OF VARIANCE; ANIMALS; CELL DIVISION; CELL SEPARATION; CULTURE MEDIA, SERUM-FREE; FEMALE; GENOTYPE; GROWTH INHIBITORS; HEMATOPOIETIC STEM CELLS; INTERLEUKIN-3; INTERLEUKIN-6; LEUKEMIA INHIBITORY FACTOR; LYMPHOKINES; MACROPHAGE INFLAMMATORY PROTEIN-1; MICE; MICE, INBRED C57BL; POLYMERASE CHAIN REACTION; RECOMBINANT PROTEINS; STEM CELL FACTOR; STIMULATION, CHEMICAL; TIME FACTORS;

EID: 0033256737     PISSN: 00212571     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. EMERSON, S.G. 1996. Ex vivo expansion of hematopoietic precursors, progenitors, and stem cells: the next generation of cellular therapeutics. Blood 87: 3082-3088.
2. BRUGGER, W., HEIMFELD, S., BERENSON, T.J. et al. 1995. Reconstitution of hematopoiesis after high-dose chemotherapy by autologous progenitor cells generated ex vivo. N. Engl. J. Med. 333: 283-287.
3. MIGLIACCIO, G., MIGLIACCIO, A.R., VALINSKY, J., LANGLEY, K., ZSEBO, K., VISSER, J.W.M. & ADAMSON, J. 1991. Stem cell factor induces proliferation and differentiation of highly enriched murine hematopoietic cells. Proc. Natl Acad. Sci. USA 88: 7420-7424.
4. BODINE, D.M., CROSIER, P.S. & CLARK, S.C. 1991. Effects of hematopoietic growth factors on the survival of primitive stem cells in liquid suspension culture. Blood 78: 914-920.
5. d mice as a single factor. Blood 79: 913-919.
6. MIURA, N., OKADA, S., ZSEBO, K.M. et al. 1993. Rat stem cell factor and IL-6 preferentially support the proliferation of c-kit-positive murine hemopoietic cells rather than their differentiation. Exp. Hematol. 21: 143-149.
7. BRANDT, J.E., BHALLA, K. & HOFFMAN, R. 1994. Effects of interleukin-3 and c-kit ligand on the survival of various classes of human hematopoietic progenitor cells. Blood 83: 1507-1514.
8. MIGLIACCIO, G., BAIOCCHI, M., ADAMSON, J.W. & MIGLIACCIO, A.R. 1996. Isolation and biological characterization of two classes of blast-cell colony-forming cells from normal murine marrow. Blood 87: 4091-4099.
9. LI, C.L. & JOHNSON, G.R. 1994. Stem cell factor enhances the survival but not the self-renewal of murine hematopoietic long-term repopulating cells. Blood 84: 408-414.
10. YONEMURA, Y. KU, H., HIRAYAMA, F. et al. 1996. Interleukin 3 or interleukin 1 abrogates the reconstituting ability of hematopoietic stem cells. Proc Natl Acad. Sci. USA 93: 4040-4044.
11. PETERS, S.O., KITTLER, S.L.W., RAMSHAW, H.S. & QUESENBERRY, P.J. 1996. Ex vivo expansion of murine marrow cells with interleukin-3 (IL-3), IL-6, IL-11, and stem cell factor leads to impaired engraftment in irradiated hosts. Blood 87: 30-37.
12. ASHIHARA, E., VANNUCCHI, A.M., MIGLIACCIO, G. & MIGLIACCIO, A.R. 1997. Growth factor receptor expression during in vitro differentiation of partially purified populations containing murine stem cells. J. Cell. Physiol. 171: 343-356.
13. TAKENAKA, K., NAGAFUJI, K., HARADA, M. et al. 1997. In vitro expansion of hematopoietic progenitor cells induces functional expression of Fas antigen (CD95). Blood 88: 2871-2877.
14. GRAHAM, G.J., WRIGHT, E.G., HEWICK, R. et al. 1990. Identification and characterization of an inhibitor of haemopoietic stem cell proliferation. Nature 344: 442-444.
15. WILLIAMS, R.L., HILTON, D.J., PEASE, S. et al. 1988. Myeloid leukaemia inhibitory factor maintains the developmental potential of embryonic stem cells. Nature 336: 684-687.
16. KELLER, J.R., BARTELMEZ, S.J., SITNICKA, E. et al. 1994. Distinct and overlapping direct effects of macrophage inflammatory protein-1α and transforming growth factor β on hematopoietic progenitor/stem cell growth. Blood 84: 2175-2181.
17. DUNLOP, D.J., WRIGHT, E.G., LORIMOR, S. et al. 1992. Demonstration of stem cell inhibition and myeloprotective effects of SCI/rhMIP la in vivo. Blood 79: 2221-2225.
18. QUESNIAUZ, V.F.J., GRAHAM, G.J. PRAGNELL, I.D. et al. 1993. Use of 5-fluorouracil to analyze the effect of macrophage inflammatory protein-1α on long-term reconstituting stem cells in vivo. Blood 81: 1497-1504.
19. SOMA, T. YU, J.M. & DUNBAR, C.E. 1996. Maintenance of murine long-term repopulating stem cells in ex vivo culture is affected by modulation of transforming growth factor-β but not macrophage inflammatory protein-1α activities. Blood 87: 4561-4567.
20. ESCARY, J.L., PERREAU, J., DUMENIL, D. et al. 1993. Leukaemia inhibitory factor is necessary for maintenance of haematopoietic stem cells and thymocyte stimulation. Nature 363: 361-364.
21. LEARY, A.G., WONG, G.G., CLARK, S.C. et al. 1990. Leukemia inhibitory factor differentiation-inhibiting activity/human interleukin for DA cells augments proliferation of human hematopoietic stem cells. Blood 75: 1960-1964.
22. FLETCHER, F.A., WILLIAMS, D.E., MALISZEWSKI, C. et al. 1990. Murine leukemia inhibitory factor enhances retroviral-vector infection efficiency of hematopoietic progenitors. Blood 76: 1098-1103.
23. + cord blood cells. In: The negative regulation of hematopoiesis. Vol. 229. M. Guigon (Ed.). John Libbey Eurotext Ldt., 155 p.
24. HARRISON, D.E. 1993. Competitive repopulation in unirradiated normal recipients. Blood 81: 2473-2474.
25. 41 and W. Embo J. 9: 1805-1813.
26. VISSER. J.W.M., BAUMAN, J.G.F., MULDER, A.H. et al. 1984. Isolation of murine pluripotent hemopoietic stem cells. J. Exp. Med. 59: 1576-1590.
27. VISSER, J.W.M. & DE VRIES, P. 1988. Isolation of spleen-colony forming cells (CFU-S ) using wheat germ agglutinin and rhodamine 123 labeling. Blood Cells 14: 369-384.
28. v mice with limiting dilutions of +/+ donor marrow cells. Proc. Natl Acad. Sci. USA 85: 7332-7335.
29. WHITNEY, III J.B. 1978. Simplified typing of mouse hemoglobin (Hbb) phenotypes using cystamine. Biochem. Genet. 16: 667-672.
30. v mice assessed by a novel quantitative PCR analysis. Br. J. Haemat. 98: 1017-1025.
31. SAMBROOK, J., KU, H., HIRAYAMA, F. et al. 1989. Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory Press, Plainview, New York.
32. WU, H., KLINGMULLER, U., BESMER, P. & LODISH, H.F. 1995. Interaction of the erythropoietin and stem-cell factor receptors. Nature 377: 242-246.
33. GODFREY, D.I., ZLOTNIK, A. & SUDA, T. 1992. Phenotypic and functional characterization of c-kit expression during intrathymic T cell development. J. Immunol. 149: 2281-2285.
34. WOLF, S.S. & COHEN, A. 1992. Expression of cytokines and their receptors by human thymocytes and thymic stromal cells. Immunology 77: 362-368.
35. RICO-VARGAS, S.A., WEISKOPH, B., NISHIKAWA, S.I. & OSMOND, D.G. 1994. c-kit expression by B cell precursors in mouse bone marrow stimulation: of B cell genesis by in vivo treatment with anti-c-kit antibody. J. Immunol. 152: 2845-2852.
36. HYRAYAMA, F. & OGAWA, M. 1995. Negative regulation of early T lymphopoiesis by interleukin-3 and interleukin-1 alpha. Blood 86: 4527-4531.
37. HIRAYAMA, F. CLARK, S.C. & OGAWA, M. 1994. Negative regulation of early B lymphopoiesis by interleukin-3 and interleukin-1 alpha. Proc. Natl Acad. Sci. USA 91: 469-473.
38. JONES, R.J., WAGNER, J.E., CELANO, P. et al. 1990. Separation of pluripotent haematopoietic stem cells from spleen colony-forming cells. Nature 347: 188-189.
39. LANSDORP, P.M. 1995. Telomere length and proliferation potential of hematopoietic stem cells. J. Cell Sci. 108: 1-6.
40. GEARING, D.P., THUT, C.J., VANDENBOS, T. et al. 1991. Leukemia inhibitory factor receptor is structurally related to the IL-6 signal transducer, gp130. EMBO J. 10: 2839-2848.
41. GEARING, D.P., COMEAU, M.R., FRIEND, D.J. et al. 1992. The IL-6 signal transducer, gp 130: an oncostatin M receptor and affinity converter for the LIF receptor. Science 255:11434-1437.
42. MCKINSTRY, W.J., LI, C.L., RASKO, J.E. et al. 1997. Cytokine receptor expression on hematopoietic stem and progenitor cells. Blood 89: 65-71.
43. SZILVASSY, S.J., WELLER, K.P., LIN, W. et al. 1996. Leukemia inhibitory factor upregulates cytokine expression by a murine stromal cell line enabling the maintenance of highly enriched competitive repopulating stem cells. Blood 87: 4618-4628.